2007年

国際老年学会欧州地区会議, 7.4-8, St.Petersburg, Russia

1. Kita T: Urinary incontinence in elderly patients with senile dementia of alzheimer type in japan

8th Asia Oceania Regional Congress of Gerontology and Geriatrics, 10.22-25, Beijing, China

1. Kita T: Atherosclerosis in the elderly -from the view of vascular cell dysfunction.
2. Kume N, Mitsuoka H, Hayashida K, Jinnai T, Tanaka M, Kita T: Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a biomarker for acute coronary syndrome (ACS).

16th ASEAN Congress of Cardiology, 4.18-21, Bali, Indonesia

1. Matsumori A: Etiology and pathogenesis of cardiomyopathies.
2. Matsumori A: New biomarkers of thrombosis and heart failure: Hepatocyte growth factor and free immunoglobulin light chains.
3. Matsumori A: Cardiomyopathy: Diagnostic and therapeutic intervention.

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 4.26, Shanghai, China

1. Matsumori A: Special Lecture. Inflammation and cardiovascular diseases. Role of hepatitis C virus, immunity and mast cells.

The 10th Toronto International Heart Failure Summit, From Pathophysiology to Clinical Practice, 6.7-9, Toronto, Canada

1. Matsumori A: Novel mechanisms in cardiomyopathy.

　

ESC Congress, 9.2-4, Vienna, Austria

1. Nishio R, Kubo H, Matsumori A: Lymphangiogenesis in heart failure.
2. Nishio R, Kubo H, Matsumori A: Role of lymphangiogenesis in experimental ischemic heart failure.
3. Matsumori A: Joint ESC/APSC session, Prognostic role of the new biomarkers.

　

Biomolecular, Infections and Immune Mechanisms. Inserm, 9.6, Paris, France

1. Matsumori A: Cardiomyopathies and heart failure

　

Great wall International Congress of Cardiology, 10.11, Beijing, China

1. Matsumori A: Global alert and response network: Hepatitis C virus-derived cardiovascular diseases.

　

European Conference on Myocardial and Pericardial Disease with Focus on Heart Disease in Women, 10.11-14, Marburg, Germany

1. Matsumori A: Treatment options in myocarditis-What we know from experimental data.

　

Molecular Therapies Targeting New Pathogenic Pathways and Networks in Human Cardiomyopathies, 10.25-27, Berlin, Germany

1. Matsumori A: Role of Hepatitis Viruses in Human Cardiomyopathies.

　

The 14th International Congress on Cardiovascular Pharmacotherapy 11.29-12.2. Antalya, Turkey

1. Matsumori A: New biomarkers for the treatment of heart failure and cardiomyopathies.
2. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Miyamoto S, Atsushi Nagasawa, Masashi Komeda, 2Masatoshi Fujita, Akira Shimatsu, Toru Kita, Koji: A Natural p300-specific Histone Acetyltransferase Inhibitor, curcumin, Prevents the Development Heart Failure in rats.

　

Arab Republic of Egypt. State Ministry of Scientific Research Institute of Ophthalmology, 12.4, Cairo, Egypt

1. Special Lecture: Matsumori A: Cardiovascular effects of hepatitis C virus.

　

The 16th Asian Pacific Congress of Cardiology, 12.15-16, Taipei, Taiwan

1. Matsumori A: The Challenger of heart failure treatment: Today and tomorrow.
2. Matsumori A: Myocarditis and related disorders in Asia.

　

Angioplasty Summit 2007、4.25-27、Korea

1. Kimura T
• Operator ：Live Case Session 3 Cases #3, #4, #5
• Operator ：Intensive Live Case Session 2
• Discussant：Live Case Session 4 Cases #6, #7, #8
• Moderator：Breakfast Meetings -#7. Drug Eluting Stent：Mini-Lectures and Case
• Discussions
• Lecturer：Breakfast Meetings -#7. Drug Eluting Stent：The J-Cypher Registry Update
• Panelist：Challenging Case Competition with Experts' Review #1. Lt. Main
• Intervention
2. Suyama T: Impact of Complete Revascularization on Long-term Outcome for Patients with Diabetes Mellitus after percutaneous Coronary Intervention in the Bare Metal Stent Era: From the CREDO-Registry.
3. Hanazawa K: Stenting for the Left Main Coronary Artery Disease with Bypass Graft Failure in a patient with Takayasu Arteretis
4. Tazaki J: Hybrid Revascularization for Embolism of Superficial Femoral Artery Supported by Retrograde Approach.
5. Tada T: A Successful Case of PCI for CTO with the Retro-grade Wire Anchoring Technique.

ENCORE SEOUL、9.6-8、Korea

1. Kimura T

• Operator：Left Main Intervention, Live Case Session: Long and Calcified Lesions
• Lecturer：Update j-Cypher Registry（Luncheon Symposium ）
• Lecturer： Overcome of DES Failure Long-term Outcome of DES PCI & Current Strategy of PCI for DES Restenosis. (Featured Lecture)

Transcatheter Cardiovascular Therapeutics 2007、10.20-25, Washington. D.C, USA

1. Kimura T

• Lecturer： The J-Cypher Multicenter "Real World" Registry ? Two Year Follow-up （Session III. DES Controversies II: Incorporating Evidence-based Medicine into Stent Selection Decision-Making ）
• Discussant： Moderated Roundtable Discussion with Audience Q&A （Session III. DES Controversies II: Incorporating Evidence-based Medicine into Stent Selection Decision-Making）
• Lecturer：The Japanese Cypher Left Main Registry 2 Year Follow-up（ Session III. Left Main Intervention Registries and Trials）
• Discussant： Moderated Discussion （Session III. Left Main Intervention Registries and Trials）Live Case Session III: Left Main Disease

Taiwan Transcatheter Therapeutics Live Course2007, 11.30-12.2, Taipei, Taiwan

1. Kimura T

• Lecture: Two-year follow-up results from j-Cypher Registry
• Operator
• Moderator

第21回国際血栓止血学会（ISTH, 2007）, 7.6-12, Geneva, Switzerland

1. Kondo H, Tabuchi A, Taniguchi R, Kawato M, Ikeda T, Morimoto T, Kita T, Horiuchi H: Aspirin efficacy: analysis of whole blood-aggregation using the screen filtration pressure method.
2. Kawato M, Shirakawa R, Kondo H, Higashi T, Ikeda T, Kita T, Horiuchi H: GTP-induced dense-granule secretion in platelets is mediated by Ral-exocyst pathway.

　

The 80th American Heart Association Annual Scientific Sessions, 11.4-7, Orlando, USA

1. Kimura T, Morimoto T, Mitsudou K, Nobuyoshi M on behalf of the j-Cypher Registry Investigators: Two Year outcome of PCI using Cypher in the real world clinical practice in Japan: Insight from the j-Cypher Registry, AHA/Japanese Cardiology Society Joint Symposium.
2. Shizuta S, Doi T, Taniguchi R, Ehara N, Nishiyama K, Furukawa Y, Tatami R, Ushijima T, Hattori R, Nishiwaki N, Tanaka M, Minami K, Sato Y, Tezuka S, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators: Long-Term Clinical Outcome of Percutaneous Coronary Intervention With Bare Metal Stent for Unprotected Left Main Coronary Artery Disease Compared With Bypass Graft Surgery: From the CREDO-Kyoto
3. Toyofuku M, Hayashi Y, Tsuchiya General Hosp, Hiroshima, Japan; Mitsudo K, Kurashiki Central Hosp, Kurashiki, Japan; Morimoto T, Kyoto Univ, Kyoto, Japan; Kimura T, Kyoto Univ Hosp, Kyoto, Japan; on behalf of j-CYPHER Investigators: Sirolimus-Eluting Stent Implantation For Unprotected Left Main Coronary Artery Disease: One Year Outcomes Insights From the J-Cypher Registry
4. Ehara N, Shizuta S, Furukawa Y, Toma M, Tamura T, Kinoshita M, Morioka S, Kihara Y, Okada Y, Suwa S, Matsui S, Himura Y, Okamoto N, Saeki A, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators: Comparison of Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft Surgery (CABG) in Diabetic Patients (pts) with Multi-Vessel Coronary Artery Disease in The Bare-Metal Stent (BMS) Era: From The Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto)
5. Nakagawa Y, Mitsudo K, Kimura T, Morimoto T, Muramatsu T, Shiode N, Kawai K, Yokoi Y, Isshiki T, Saku K, Doi O, on behalf of the j-CYPHER Registry investigators Incidence and Predictor of Late Stent Thrombosis After Implantation of Sirolimus-eluting Stent: From Two-year Clinical Follow-up of The j-Cypher Registry
6. Abe M, Taniguchi R, Ehara N, Saito N, Shizuta S, Furukawa Y, Okazaki K, Sakurai T, Kataoka K, Ogawa H, Kawasuji M, Hirai T, Maeda S, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T: Contrast-Induced Nephropathy After Percutaneous Coronary Intervention is Associated With High Long-Term Mortality: Insights From CREDO-Kyoto Registry
7. Takaya T, Kawamura T, Ono K, Takanabe R, Kaichi S, Kita T, Wada H, Morimoto T, Shimatsu A, Hasegawa K: Roles of muscle-specific microRNAs during differentiation of mouse embryonic stem cells into cardiac myocytes.
8. Kaichi S, Takaya T, Morimoto T, Sunagawa Y, Kawamura T, Ono K, Kita T, Hidaka K, Morisaki T, Shimatsu A, Baba S, Heike T, Nakahata T, Hasegawa K: Cyclin-dependent kinases-9, a novel component of p300/GATA4 complex, is involved in the differentiation of mouse ES cells into cardiac myocytes.
9. Sunagawa Y, Morimoto T, Kawamura T, Takaya T, Wada H, Shimatsu A, Hasegawa K, Fujita M, Kita T: Proteomics analysis indentifies positive transcription elongation factor b as a novel GATA-4-binding partner involved in hypertrophic responses in cardiomyocytes.
10. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Shimatsu A, Hasegawa K, Miyamoto S, Nagasawa A, Komeda M, Fujita M, Kita T: Curcumin, a natural p300-specific histone acetyltransferase inhibitor, prevents the development of heart failure in rats.
11. Miyamoto S, Inoko M, Nagai K, Nakane E, Abe T, Sasaki K, Nakashima J, Tanaka N, Uehara K, Ueyama K, Hosokawa R, Nohara R, Fujita M: Elevation of pericardial fluid active matrix metalloproteinase-9 (MMP-9) level is closely associated with left ventricular remodeling.
12. Horiuchi H, Sumi K, Tabuchi A, Taniguchi R, Oga T, Chin K, Mishima M, Kita T: Increased platelet aggregability in obstructive sleep apnea syndrome patients is improved by nasal continuous positive airway pressure treatment.
13. Inuzuka Y, Shioi T, Kato T, Tamaki Y, Kawashima K, Iwanaga Y, Kita T, Yoshida Y, Kosugi R, Watanabe-Maeda K, Machida Y, Izumi T. Suppression of Insulin Signaling Attenuates Cardiac Aging in Mice.
14. Kato T, Shioi T, Niizuma S, Tamaki Y, Inuzuka Y, Kawashima T, Iwanaga Y, Kita T, Soga T. Metabolomic Analysis of the Transition from Cardiac Hypertrophy to Failure.
15. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Ono K, Shioi T, Kita T. Chronic Administration of Endogenous Inotropic Peptide, Apelin, Prevents Left Ventricular Remodeling and Improves Survival in Hypertensive Rats with Heart Failure.
16. Akao M, Matsumoto-Ida M, Kato M, Iguchi M, Takeda T, Kita T. "Effects of cardioprotective drugs on mitochondrial functions during myocardial ischemia/reperfusion revealed by real-time two-photon imaging of perfused rat hearts."
17. Kato M, Akao M, Makiyama T, Matsumoto-Ida M, Iguchi M, Takeda T, Kita T. "The targeting of cyclophilin D by RNA interference as a novel therapeutic strategy against myocardial ischemia/reperfusion injury."
18. Makiyama T, Akao M, Shizuta S, Doi T, Ohno S, Nishio Y, Kimura T, Horie M, Kita T: Familial Dilated Cardiomyopathy with Conduction Disease Caused by a Lamin A/C Mutation: Clinical Efficacy of Cardiac Resynchronization Therapy with a Defibrillator.
19. Ono K, Horie T, Abe Y, Kawamura T, Kinoshita M, Nishi H, Nagao K, Satoh N, Shimatsu A, Kita T, Hasegawa K: Serotonin in adipose tissue acts as an autocrine factor required for adipocyte differentiation and lipolysis.
20. Horie T, Ono K, Abe Y, Kawamura T, Shimatsu A, Kita T, Hasegawa K: Activation of smad transcriptional coreppressor TGIF by insulin is required for adipocyte differentiation.
21. Horie T, Ono K, Iwanaga Y, Nishi H, Nagao K, Kinoshita M, Mori R, Hasegawa K, Kita T: MicroRNA-133 regulates the expression of CPT-1b and GLUT4 by targeting SRF and KLF15 and is involved in metabolic control in cardiac myocytes.
22. Horie T, Ono K, Abe Y, Kawamura T, Wada H, Kinoshita M, Nagao K, Nishi H, Shimatsu A, Kita T, Hasegawa K: Oxidative stress induces GLUT4 translocation by dual AMPK kinase activation in cardiac myocytes
23. Nishi H, Ono K, Iwanaga Y, Horie T, Kinoshita M, Nagao K, Mori R, Hasegawa K, Kita T: MicroRNA-206 controls cardiac myosin heavy chain gene expression by targeting RXR-a.
24. Sugimoto M, Arai H, Tamura Y, Murayama T, Ono K, Ariyasu H, Akamizu T, Kita T, Kamei K, Yokode M: Mulberry leaf ameliorates the production of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice.
25. Tamura Y, Arai H, Sugimoto M, Murayama T, Ueda Y, Kanamori H, Ono K, Ariyasu H, Akamizu T, Kita T, Yokode M: C-C chomokine receptor-2 inhibitor ameliorates insulin resistance and hepatic steatosis in db/db mice.

　

第76回欧州動脈硬化学会(EAS)　Late Breaking Session, 6.10-14, Helsinki, Finland

1. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T: Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) is a prognostic biomarker after acute coronary syndrome to predict recurrence or death.

　

16th International Symposium on Drugs Affecting Lipid Metabolism (DALM), 10.4-7, NY, USA

1. Koshiyama H, Taniguchi A, Tanaka K, Kagimoto S, Fujioka Y, Hirata K, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, Fujimoto S, Hamamoto Y, Honjo S, Ikeda H, Nabe K, Tsuda K, Inagaki N, Seino Y, Kume N: Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia.

　

Cardio Rhythm 2007, 2.2-4, Hong Kong, China

1. Ohno S: A novel mutation inassociated with a case of Jervell Lange-Nielsen syndrome in a Japanese family.

　

The 56th Annual Scientific Session of the American College of Cardiology, 3.24-27, New Orleans, USA

1. Furukawa Y, Shizuta S, Haruna Y, Ehara N, Taniguchi R, Hoshino K, Tamura T, Kawanami M, Kadoya M, Matsuyama E, Miki S, Yoshida A, Nakajima H, Sasae H, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T. Impact of pharmacologic management at discharge for complicated risk factors on outcomes of diabetic. patients undergoing first coronary revascularization: Perspectives from CREDO-Kyoto registry.
2. Shizuta S, Ehara N, Taniguchi R, Haruna Y, Furukawa Y, Mitsuoka H, Doi T, Saito N, Miura A, Kotoura H, Aota M, Eizawa, H Kato H, Miki I, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T: Comparison of Percutaneous Coronary Intervention and Bypass Surgery in Patients With Multi-Vessel Coronary Artery Disease and Reduced Left Ventricular Function in the Bare Metal Stent Era.
3. Shizuta S, Taniguchi R, Ehara N, Doi T, Nishiyama K, Furukawa Y, Nakagawa Y, Tatami R, Ushijima T, Hattori R, Shirotani M, Nishiwaki N, Tanaka M, Minami K, Sato Y, Tezuka S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T: Comparison of Percutaneous Coronary Intervention and Bypass Surgery Among Patients With a Chronic Total Occlusion and Multi-Vessel Coronary Artery Disease in the Bare Metal Stent Era.
4. Tamura T: A Prospective Registry to Evaluate an Implantation of Sirolimus-Eluting Stent in Bifurcation Lesions: Comparison of Simple versus Complex Stenting Techniques; Long-Term Clinical Outcome from The j-Cypher Registry
5. Nishiyama K, Shizuta S, Taniguchi R, Ehara N, Haruna Y, Abe M, Toma M, Yutaka Furukawa Y, Satoshi Kaburagi S, Doi O, Kambara H, Nara M, Matsuda K, Hamasaki S, Tei C, Yamamoto H, Sakata R, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T: Chronic Obstructive Pulmonary Disease was an Independent Predictor of Sudden Cardiac Death, Cardiac Death and All-cause Mortality after Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
6. Toyofuku M, Hayashi Y, Mitsudo K, Morimoto T, Kimura T, on behalf of j-CYPHER Investigators, Sirolimus-eluting Stent Implantation For The Percutaneous Treatment Of Unprotected Left Main Coronary Artery Disease: A Clinical Analysis Based On J-Cypher Registry.
7. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T: Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) is a prognostic biomarker after acute coronary syndrome to predict recurrence or death. 8) Fujita M, Yamazaki T, Hayashi D, Nagai R, The JCAD Study Investigators: Lipid-independent effects of statins on cardiovascular events in the Japanese Coronary Artery Disease Study: Comparison between hydrophilic and lipophilic statins.

American Society of Nephrology Meeting, 11.3-4, San Francisco, USA

1. Yanagita M: Balance between BMP-7 and USAG-1, a novel BMP antagonist abundantly expressed in the kidney, during kidney disease and development.
2. Yanagita M: Genetic dissection of the role of Grem1 in nephrogenesis.

The 17th European Meeting on Hypertension, 6.15-19, Milan, Italy

1. Takase B, Takeishi Y, Hirai T, Lee JD, Uzui H, Senda S, Miwa K, Hiraoka Y, Kinugawa T, Hosokawa R, Fujita M: Beneficial effect of combined treatment of amlodipine and betaxolol on cardiac autonomic activity assessed by heart rate variability in patients with poorly controlled hypertension.

The 3rd China-Japan Cardiovascular Forum (CJCF), 10.10-11, Beijing, China

1. Fujita M: New findings in pleiotropic effects of statins.
2. Sunagawa Y, Morimoto T, Takaya T, Fujita M, Kita T, Hasegawa K: P-TEFb is a novel component of p300/GATA-4 complex required for hypertrophic responses in cardiac myocytes
3. Takaya T, Kawamura T, Morimoto T, Ono K, Shimatsu A, Hasegawa K: Identification of p300-targeted acetylated residues in GATA-4 during hypertrophic responses in cardiac myocytes.

Keystone Symposia, 1.22-27, Colorado, USA

1. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Fujita M, Kita T, Hasegawa K: A Natural p300-specific Histone Acetyltransferase Inhibitor, Crucumin, Prevents the Development of Hypertension-induced Heart Failure in salt-sensitive Dahl Rats

The 1st International Society of Cardiomyopathy and Heart Failure, 3.10-13, 20, Kyoto, Japan

1. Sunagawa Y, Morimoto T, Kawamura T, Takaya T, Wada H, Shimatsu A, Kita T, Hasegawa K: Curcumin, a Natural p300-specific HAT Inhibitor, Represses Hypertrophic Responses in Cardiac Myocytes

The 24th Annual Meeting of ISHR Japanese Section, 6.21, Ferrara, Italia

1. Morimoto T, Sunagawa Y, Takaya T, Hasegawa K, Fujita M, Kita T: Crucumin, A Natural p300-specific Histone Acetyltransferase Inhibitor, Prevents the Development of Heart Failure in vivo.

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.